Cargando…

Teriflunomide and Epstein–Barr virus in a Spanish multiple sclerosis cohort: in vivo antiviral activity and clinical response

BACKGROUND: Epstein–Barr virus (EBV) and human herpesvirus 6 (HHV-6) have been associated with multiple sclerosis (MS). Teriflunomide is an oral disease-modifying therapy approved for treatment of relapsing forms of MS. In the preclinical Theiler’s murine encephalitis virus model of MS, the drug dem...

Descripción completa

Detalles Bibliográficos
Autores principales:	Domínguez-Mozo, María Inmaculada, González-Suárez, Inés, Villar, Luisa María, Costa-Frossard, Lucienne, Villarrubia, Noelia, Aladro, Yolanda, Pilo, Belén, Montalbán, Xavier, Comabella, Manuel, Casanova-Peño, Ignacio, Martínez-Ginés, María Luisa, García-Domínguez, Jose Manuel, García-Martínez, María Ángel, Arroyo, Rafael, Álvarez-Lafuente, Roberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10570817/ https://www.ncbi.nlm.nih.gov/pubmed/37841253 http://dx.doi.org/10.3389/fimmu.2023.1248182

Ejemplares similares

Mitochondrial Impairments in Peripheral Blood Mononuclear Cells of Multiple Sclerosis Patients
por: Domínguez-Mozo, María Inmaculada, et al.
Publicado: (2022)

Anti-Human Herpesvirus 6 A/B Antibodies Titers Correlate With Multiple Sclerosis-Associated Retrovirus Envelope Expression
por: Pérez-Pérez, Silvia, et al.
Publicado: (2021)

Teriflunomide induces a tolerogenic bias in blood immune cells of MS patients
por: Medina, Silvia, et al.
Publicado: (2019)

Herpesvirus Antibodies, Vitamin D and Short-Chain Fatty Acids: Their Correlation with Cell Subsets in Multiple Sclerosis Patients and Healthy Controls
por: Dominguez-Mozo, Maria Inmaculada, et al.
Publicado: (2021)

Epstein-Barr Virus and multiple sclerosis in a Spanish cohort: A two-years longitudinal study
por: Domínguez-Mozo, María Inmaculada, et al.
Publicado: (2022)

Epstein-Barr Virus Load Correlates with Multiple Sclerosis-Associated Retrovirus Envelope Expression
por: Pérez-Pérez, Silvia, et al.
Publicado: (2022)

Acetate correlates with disability and immune response in multiple sclerosis
por: Pérez-Pérez, Silvia, et al.
Publicado: (2020)

Predictive factors and early biomarkers of response in multiple sclerosis patients treated with natalizumab
por: Dominguez-Mozo, Maria Inmaculada, et al.
Publicado: (2020)

Serum Levels of CXCL13 Are Associated With Teriflunomide Response in Patients With Multiple Sclerosis
por: Fissolo, Nicolás, et al.
Publicado: (2022)

Evolution of antibody titres against Epstein–Barr virus and human herpesvirus 6A/B and expression of multiple sclerosis-associated retrovirus in the serum of pregnant multiple sclerosis patients
por: Pérez-Pérez, Silvia, et al.
Publicado: (2021)

Anti-Human Herpesvirus 6A/B IgG Correlates with Relapses and Progression in Multiple Sclerosis
por: Ortega-Madueño, Isabel, et al.
Publicado: (2014)

Identification of the Immunological Changes Appearing in the CSF During the Early Immunosenescence Process Occurring in Multiple Sclerosis
por: Picón, Carmen, et al.
Publicado: (2021)

MHC2TA mRNA levels and human herpesvirus 6 in multiple sclerosis patients treated with interferon beta along two-year follow-up
por: Dominguez-Mozo, Maria Inmaculada, et al.
Publicado: (2012)

Teriflunomide in Patients with Relapsing–Remitting Forms of Multiple Sclerosis
por: Chan, Andrew, et al.
Publicado: (2016)

MicroRNAs Associated with Disability Progression and Clinical Activity in Multiple Sclerosis Patients Treated with Glatiramer Acetate
por: Casanova, Ignacio, et al.
Publicado: (2023)

A Polymorphism Within the MBP Gene Is Associated With a Higher Relapse Number in Male Patients of Multiple Sclerosis
por: Espino-Paisán, Laura, et al.
Publicado: (2020)

Peripheral myeloid-derived suppressor cells are good biomarkers of the efficacy of fingolimod in multiple sclerosis
por: Camacho-Toledano, Celia, et al.
Publicado: (2022)

MicroRNAs of Human Herpesvirus 6A and 6B in Serum and Cerebrospinal Fluid of Multiple Sclerosis Patients
por: Domínguez-Mozo, María I., et al.
Publicado: (2020)

Epidemiology of multiple sclerosis and vitamin D levels in Lanzarote, Canary Islands, Spain
por: Pérez-Pérez, Silvia, et al.
Publicado: (2019)

microRNA Expression and Its Association With Disability and Brain Atrophy in Multiple Sclerosis Patients Treated With Glatiramer Acetate
por: Dominguez-Mozo, María I., et al.
Publicado: (2022)

Psychological Problems Derived from Mastectomy: A Qualitative Study
por: Arroyo, José Manuel García, et al.
Publicado: (2011)

Role of B Cell Profile for Predicting Secondary Autoimmunity in Patients Treated With Alemtuzumab
por: Walo-Delgado, Paulette Esperanza, et al.
Publicado: (2021)

Integrated Management of Multiple Sclerosis Spasticity and Associated Symptoms Using the Spasticity-Plus Syndrome Concept: Results of a Structured Specialists' Discussion Using the Workmat(®) Methodology
por: Fernandez, Oscar, et al.
Publicado: (2021)

Treatment of Multiple Sclerosis With Teriflunomide. Multicenter Study of Real Clinical Practice in the Valencian Community-Spain
por: Landete, Lamberto, et al.
Publicado: (2021)

Molecular signature associated with cladribine treatment in patients with multiple sclerosis
por: Fissolo, Nicolas, et al.
Publicado: (2023)

The DNA Copy Number of Human Endogenous Retrovirus-W (MSRV-Type) Is Increased in Multiple Sclerosis Patients and Is Influenced by Gender and Disease Severity
por: Garcia-Montojo, Marta, et al.
Publicado: (2013)

CSF Chitinase 3–Like 2 Is Associated With Long-term Disability Progression in Patients With Progressive Multiple Sclerosis
por: Comabella, Manuel, et al.
Publicado: (2021)

Short- and Long-Term Humoral and Cellular Immune Responses to SARS-CoV-2 Vaccination in Patients with Multiple Sclerosis Treated with Disease-Modifying Therapies
por: Sainz de la Maza, Susana, et al.
Publicado: (2023)

Establishing the best combination of the kappa free light chain index and oligoclonal bands for an accurate diagnosis of multiple sclerosis
por: Monreal, Enric, et al.
Publicado: (2023)

The Broad Concept of “Spasticity-Plus Syndrome” in Multiple Sclerosis: A Possible New Concept in the Management of Multiple Sclerosis Symptoms
por: Fernández, Óscar, et al.
Publicado: (2020)

Predicting Aggressive Multiple Sclerosis With Intrathecal IgM Synthesis Among Patients With a Clinically Isolated Syndrome
por: Monreal, Enric, et al.
Publicado: (2021)

Teriflunomide as a therapeutic means for myelin repair
por: Göttle, Peter, et al.
Publicado: (2023)

Genomic Multiple Sclerosis Risk Variants Modulate the Expression of the ANKRD55–IL6ST Gene Region in Immature Dendritic Cells
por: Mena, Jorge, et al.
Publicado: (2022)

HERV-W polymorphism in chromosome X is associated with multiple sclerosis risk and with differential expression of MSRV
por: García-Montojo, Marta, et al.
Publicado: (2014)

Leflunomide/teriflunomide inhibit Epstein-Barr virus (EBV)-induced lymphoproliferative disease and lytic viral replication
por: Bilger, Andrea, et al.
Publicado: (2017)

Genetic variation in NDFIP1 modifies the metabolic patterns in immune cells of multiple sclerosis patients
por: López-Cotarelo, Pilar, et al.
Publicado: (2021)

Inflammation in multiple sclerosis induces a specific reactive astrocyte state driving non‐cell‐autonomous neuronal damage
por: Matute‐Blanch, Clara, et al.
Publicado: (2022)

Blood CD8+ Naïve T-Cells Identify MS Patients with High Probability of Optimal Cellular Response to SARS-CoV-2 Vaccine
por: Rodero-Romero, Alexander, et al.
Publicado: (2023)

Chitinases and chitinase-like proteins as biomarkers in neurologic disorders
por: Pinteac, Rucsanda, et al.
Publicado: (2020)

Adaptive Features of Natural Killer Cells in Multiple Sclerosis
por: Moreira, Antía, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_me0rjr0b1kei5e37jmrae1iue8